DLK Investment Management’s AbbVie ABBV Stock Holding History

DLK Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$335K	Buy	1,953 +7	+0.4%	+$1.51K	0.14%	63
2026 Q1	$423K	Sell	1,946 -7	-0.4%	-$1.55K	0.17%	53
2025 Q4	$446K	Hold	1,953	–	–	0.17%	53
2025 Q3	$452K	Hold	1,953	–	–	0.17%	51
2025 Q2	$363K	Hold	1,953	–	–	0.14%	60
2025 Q1	$409K	Hold	1,953	–	–	0.17%	50
2024 Q4	$347K	Hold	1,953	–	–	0.15%	56
2024 Q3	$386K	Hold	1,953	–	–	0.15%	63
2024 Q2	$335K	Hold	1,953	–	–	0.14%	64
2024 Q1	$356K	Hold	1,953	–	–	0.15%	61
2023 Q4	$303K	Buy	+1,953	New	+$285K	0.14%	65

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

DLK Investment Management's ABBV Position: Q2 2026 in Review

DLK Investment Management increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,953 shares worth $335K. The position accounts for 0.14% of the portfolio, ranked #63.

DLK Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $452K in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

DLK Investment Management held 1,953 shares of AbbVie worth $335K as of Q2 2026.
DLK Investment Management bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
AbbVie made up 0.14% of DLK Investment Management's portfolio in Q2 2026, its #63 holding.
DLK Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
DLK Investment Management's AbbVie position peaked at $452K in Q3 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.